Category Cancer Biomarkers and Therapeutics
Raf kinase inhibitor protein (RKIP) as a novel predictor of molecular targeted therapies response in solid tumors
Read More
SynCroTher – New chromene derivatives for cancer therapy
Read More
Establishment of a patient-derived xenograft CAM model for in vivo validation of the new anticancer drug candidate SM01 – CAMAvatar
Read More
WNTrack – Tracking brain tumors through their exosomes: a WNT6-driven approach
Read More
Exploiting the immune landscape of HOXA9/WNT6-driven glioblastoma: opportunities for novel precision therapies
Read More
Exploiting novel oncogenic players in glioblastoma
Read More
Multi-omic networks in gliomas (MONET)
Read More
Embryonic T-box transcription factor Brachyury: Dissecting its role in prostate cancer biology and clinical application
Read More
SENTINEL – Novel injectable biosensor for continuous remote monitoring of cancer patients at high-risk of relapse
Read More
Contact us
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″
Copyright ©2022 ICVS. All Rights Reserved
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″